Anna Eshoo: “the United States of America is the most extraordinary market for drugs. We have an insatiable appetite for drugs in our…”

The Medicaid Value-Based Payments for Patients Act will codify a CMS rule to help ensure Medicaid enrollees have access to breakthrough gene therapies.

I find it hypocritical when I hear time and time and time again that plans are often blocked by PBMs from offering the lowest-priced generic.

We need to get a clear explanation from hospitals on why, after hospitals acquire physician practices, the prices for the services provided by the acquired physicians increases by 14 percent.

I think that, you know, to a person--well, maybe not to a--well, just--I am getting myself in a little trouble here.